Purespring Therapeutics
Purespring Therapeutics is a gene therapy provider for kidney diseases founded in 2020.
2
Funding Rounds
$155.0m
Money raised
Funding
Funding series
Funding Series Analysis
The company Purespring Therapeutics has raised a total of $155m in funding over 2 rounds.
Key Insights:
- Purespring Therapeutics Series B Round, October 2024: $105m
- Purespring Series A round, July 30, 2021: $50m
Purespring Therapeutics Series B Round, October 2024
$105m
Purespring Series A round, July 30, 2021
$50m
Industries
Purespring Therapeutics is active in the following industries: